Blac Chyna Reportedly Denies Rob Kardashian's Allegations That She’s A Violent Drug Addict

Blac Chyna Reportedly Denies Rob Kardashian’s Allegations That She’s A Violent Drug Addict

Rob Kardashian is reportedly seeking primary custody of his daughter, Dream. In legal docs Kardashian filed, he accused Blac Chyna of being an unfit mother, claiming she’s a drunk drug addict. He claims she snorts cocaine and has had violent outbursts, including throwing a sharp object at a hairdresser. TMZ reported Rob believes her behavior … Read more…

Bristol-Myers Squibb, Gilead Sciences, and Biogen hike US drug prices

Bristol-Myers Squibb, Gilead Sciences, and Biogen hike US drug prices

From l-r, Giovanni Caforio, M.D. Chairman of the Board and Chief Executive Officer Bristol-Myers Squibb Co., Jennifer Taubert, Executive Vice President, Worldwide Chairman, Janssen Pharmaceuticals Johnson & Johnson, and Kenneth C. Frazier, Chairman and Chief Executive Officer Merck & Co., Inc., take their seats as they wait to testify before the Senate Finance Committee hearing … Read more…

'I was bleeding' - Solidstar narrates near-death experience after drug overdose

‘I was bleeding’ – Solidstar narrates near-death experience after drug overdose

Joshua Iniyezo, Nigerian singer better known as Solidstar, has narrated how he nearly died from bleeding after overdosing on drugs. The Delta-born star took to his Insta story on Tuesday to share a post where he recounted how he had overdosed on drugs. He added that the incident, which occurred few days back, led to … Read more…

NCB dents an int''l drug cartel, arrest 9 modules, seizes 20 kg cocaine

NCB dents an int”l drug cartel, arrest 9 modules, seizes 20 kg cocaine

(Eds: (Adding details, fixing typo in heading)) New Delhi, Dec 14 (PTI) The NCB has arrested nine persons, including four foreigners, and seized 20 kgs of high-quality cocaine worth Rs 100 crore belonging to an international drug cartel, rasing the value of its seized contraband in recent months to Rs 1,300 crore, an official said … Read more…

In surprise decision, US approves muscular dystrophy drug

In surprise decision, US approves muscular dystrophy drug

A logo sign outside of the headquarters of Sarepta Therapeutics, Inc, in Cambridge, Massachusetts on February 21, 2018. Kristoffer Tripplaar | AP U.S. health regulators approved a second drug for a debilitating form of muscular dystrophy, a surprise decision after the medication was rejected for safety concerns just four months ago. The ruling marks the … Read more…

CNBC logo

House passes Speaker Nancy Pelosi’s drug pricing bill

Speaker of the House Nancy Pelosi, December 10, 2019. Saul Loeb | AFP | Getty Images The House of Representatives on Thursday passed Speaker Nancy Pelosi’s drug pricing legislation, a sweeping bill that will allow the U.S. government to negotiate lower prices on the costliest drugs each year. The legislation, which passed the House 230 … Read more…

Drug prices and health-care are wild cards in the 2020 election

Drug prices and health-care are wild cards in the 2020 election

Democratic presidential candidates (L-R) former tech executive Andrew Yang, South Bend, Indiana Mayor Pete Buttigieg, former Vice President Joe Biden, Sen. Bernie Sanders (I-VT), Sen. Kamala Harris (D-CA) and Sen. Kirsten Gillibrand (D-NY) take part in the second night of the first Democratic presidential debate on June 27, 2019 in Miami, Florida. Drew Angerer | … Read more…

Pelosi agrees to expand drug price bill to win support from AOC, other Democrats

Pelosi agrees to expand drug price bill to win support from AOC, other Democrats

Speaker of the House Nancy Pelosi (D-CA) at a press conference, September 19, 2019 in Washington, DC. Win McNamee | Getty Images House Speaker Nancy Pelosi has brokered a deal with a key block of Democrats that threatened to derail passage of her sweeping bill overhauling drug prices. Pelosi met late Tuesday with Reps. Pramila … Read more…

Investors fear Pelosi's drug price plan will kill small biotech firms

Investors fear Pelosi’s drug price plan will kill small biotech firms

Private equity investors are lobbying against Nancy Pelosi’s sweeping drug pricing bill, telling her legislative aides in a series of private meetings in recent weeks that the plan would dry up financing for small biotech companies. A group of venture capitalists, including Peter Kolchinsky of RA Capital Management, Johannes Fruehauf of BioInnovation Capital and Sara … Read more…